Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul-Aug;11(4):381-388.
doi: 10.32598/bcn.9.10.485. Epub 2020 Jul 1.

MDMA and the Brain: A Short Review on the Role of Neurotransmitters in Neurotoxicity

Affiliations
Review

MDMA and the Brain: A Short Review on the Role of Neurotransmitters in Neurotoxicity

Nor Suliana Mustafa et al. Basic Clin Neurosci. 2020 Jul-Aug.

Abstract

N-Methyl-3, 4-methylenedioxyamphetamine (MDMA), or ecstasy is a recreational drug of abuse. It is a synthetic substance that affects the body's systems, which its mechanism of action and treatment should be more investigated. MDMA provides an immediate enjoyable feeling by stimulating the release of neurotransmitters, such as dopamine and serotonin in the brain. Unfortunately, abnormal regulation of the brain neurotransmitters, as well as the increased oxidative stress causes damage to the brain neurons after the MDMA exposure. Only a few studies have been done regarding its treatment. Thus, the treatment of MDMA complications should be further explored mainly by targeting its mechanism of action in the neurotransmitter systems. Hence, this study presents a short review regarding the recent findings on the role of neurotransmitters to cause MDMA neurotoxicity. The results will be useful for future research in elucidating the potential treatment based on the targeted mechanisms to treat the neurotoxic effects of MDMA.

Keywords: Brain injuries; MDMA; Memory; Neurotransmitter; Therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declared no conflict of interest.

References

    1. Anneken J. H., Cunningham J. I., Collins S. A., Yamamoto B. K., Gudelsky G. A. (2013). MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: Role of cyclooxygenase. Journal of NeuroImmune Pharmacology, 8(1), 58–65. [DOI:10.1007/s11481-012-9420-x] [PMID ] [PMCID ] - DOI - PMC - PubMed
    1. Asl S. S., Pourheydar B., Dabaghian F., Nezhadi A., Roointan A., Mehdizadeh M. (2013). Ecstasy-induced caspase expression alters following ginger treatment. Basic and Clinical Neuroscience, 4(4), 329–33. http://bcn.iums.ac.ir/article-1-437-en.html - PMC - PubMed
    1. Baumann M. H., Wang X., Rothman R. B. (2007). 3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: A reappraisal of past and present findings. Psychopharmacology, 189(4), 407–24. [DOI:10.1007/s00213-006-0322-6] [PMID ] [PMCID ] - DOI - PMC - PubMed
    1. Bradbury S. (2014). The Role of Serotonin in MDMA Self-administration in rats. Wellington: Victoria University of Wellington; http://hdl.handle.net/10063/3672
    1. Breivik T., Bogen I. L., Haug K. H., Fonnum F., Opstad P. K., Eide D. M., et al. (2014). Effects of long-term exposure of 3, 4-methylenedioxymethamphetamine (MDMA;”ecstasy”) on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats. Neurochemistry International, 72, 30–6. [DOI:10.1016/j.neuint.2014.04.002] [PMID ] - DOI - PubMed

LinkOut - more resources